Neurodegeneration in Alzheimer's disease and glaucoma: overlaps and missing links.
Sagnik SenRohit SaxenaManjari TripathiDeepti VibhaRebika DhimanPublished in: Eye (London, England) (2020)
The eye is said to be the window into the brain. Alzheimer's disease (AD) and glaucoma both being diseases of the elderly, have several epidemiological and histological overlaps in pathogenesis. Both these diseases are neurodegenerative conditions. Over the years, a consensus has developed that both may be two ends of a singular spectrum of diseases. Epidemiological studies have shown that more Alzheimer's patients may be suffering from glaucoma than general healthy population. Retinal ganglion cell damage is a characteristic of both diseases, along with discovery of amyloid-β and tau protein deposition in the retina and aqueous humor of eye. The latter two proteins are known to be pathognomonic of AD. Other pathways such as the insulin receptor pathway also seem to be affected in both diseases similarly. In spite of these overlaps, there are few missing links which still need more evidence, namely, intraocular pressure mechanisms, cerebrospinal fluid pressure and trans-lamina cribrosa pressure gradients, vascular autoregulation factors, etc. Several factors point towards a common pathogenesis at some level for both diseases and prospective studies are necessary to study the natural course of both diseases.
Keyphrases
- type diabetes
- end stage renal disease
- chronic kidney disease
- small molecule
- ejection fraction
- newly diagnosed
- optic nerve
- single cell
- prognostic factors
- mesenchymal stem cells
- high throughput
- ionic liquid
- bone marrow
- skeletal muscle
- metabolic syndrome
- brain injury
- weight loss
- cerebral ischemia
- community dwelling
- amino acid